| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.06 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.07 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.091 | 0.07 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |